CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (UNAUDITED) - USD ($) $ in Thousands	Total	Cumulative Translation Adjustment	Securities Purchase Agreement	Common Stock	Common Stock Securities Purchase Agreement	Additional Paid - In Capital	Additional Paid - In Capital Securities Purchase Agreement	Subscription Receivable	Cumulative Translation Adjustment	Accumulated Deficit	Accumulated Deficit Cumulative Translation Adjustment
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023				9,131,252
Stockholders' equity, beginning balance at Dec. 31, 2023	$ (51,024)	$ 22		$ 1		$ 319,992		$ (698)	$ (345)	$ (369,974)	$ 22
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	1,070					1,070
Issuance of shares in connection with Equity Interest Payment Agreement (in shares)				45,269	450,300
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs	1,038		$ 1,133			340	$ 1,133	698
Restricted shares award issuance (in shares)				159,357
Issuance of warrants in connection with Securities Purchase Agreement	4,866					4,866
Reclassification of foreign currency translation adjustment realized upon liquidation of foreign subsidiary	0
Foreign currency translation adjustment	(3)								(3)
Net loss	(3,944)									(3,944)
Stockholders' equity ending balance (in shares) at Mar. 31, 2024				9,786,178
Stockholders equity, ending balance at Mar. 31, 2024	$ (46,842)			$ 1		327,401		0	(348)	(373,896)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2024	13,025,627			13,025,627
Stockholders' equity, beginning balance at Dec. 31, 2024	$ (55,754)			$ 1		334,330		0	(348)	(389,737)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	543					543
Issuance of shares in connection with Equity Interest Payment Agreement (in shares)					752,742
Issuance of shares in connection with Securities Purchase Agreement and Issuance of shares, net of issuance costs			$ 1,370				$ 1,370
Restricted shares award issuance (in shares)				303,549
Issuance of shares in connection with Debt Exchange Agreements (in shares)				643,456
Issuance of shares in connection with Debt Exchange Agreements	815					815
Reclassification of foreign currency translation adjustment realized upon liquidation of foreign subsidiary	348								348
Foreign currency translation adjustment	0
Net loss	$ (5,564)									(5,564)
Stockholders' equity ending balance (in shares) at Mar. 31, 2025	14,725,374			14,725,374
Stockholders equity, ending balance at Mar. 31, 2025	$ (58,242)			$ 1		$ 337,058		$ 0	$ 0	$ (395,301)